Desmopressin for Bedwetting in Children With SCD

Status Terminated

Clinical Trial Summary

This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.

Clinical Trial Description

Night time bedwetting is a common complication of sickle cell disease, and affects up to 30 % of children. Desmopressin is an oral medication that increases water reabsorption in the kidneys. Studies have shown that it is effective in decreasing bedwetting episodes in children without sickle cell disease. Chronic sickling episodes causing damage to the kidneys could cause permanent damage and may make this treatment ineffective in sickle cell disease. This trial will inform pediatric sickle cell doctors if desmopressin is an appropriate treatment for bed wetting in the investigators patients. This study expanded upon a previously terminated study which had separately registered (NCT02636387, ID: 2014-3768). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04420585
Study type	Interventional
Source	Montefiore Medical Center
Contact
Status	Terminated
Phase	Phase 4
Start date	July 7, 2020
Completion date	June 12, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06078696` - Siplizumab for Sickle Cell Disease Transplant	Phase 1/Phase 2
Completed	`NCT04134299` - To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease	N/A
Completed	`NCT02561312` - Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell
Completed	`NCT00890396` - Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study)
Completed	`NCT00059293` - Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Terminated	`NCT00034528` - Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia	Phase 2
Completed	`NCT00005277` - Cooperative Study of The Clinical Course of Sickle Cell Disease	N/A
Active, not recruiting	`NCT04170348` - Daily Vitamin D for Sickle-cell Respiratory Complications	Phase 2
Completed	`NCT04584528` - Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease	N/A
Recruiting	`NCT02286154` - Therapeutic Response Evaluation and Adherence Trial (TREAT)	N/A
Completed	`NCT02857023` - Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease	N/A
Withdrawn	`NCT01925001` - Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis	Phase 2
Terminated	`NCT00122980` - Stroke With Transfusions Changing to Hydroxyurea	Phase 3
Completed	`NCT00246077` - Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport	N/A
Completed	`NCT00094887` - Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises	Phase 2
Completed	`NCT00035763` - Pain in Sickle Cell Epidemiologic Study	N/A
Terminated	`NCT04091737` - CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease	Phase 1
Completed	`NCT00005300` - Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease	N/A
Recruiting	`NCT04351698` - SMILES: Study of Montelukast in Sickle Cell Disease	Phase 2/Phase 3
Not yet recruiting	`NCT06290401` - A Socio-ecological Approach for Improving Self-management in Adolescents With SCD	Phase 2